D-0404-2025 Class II Ongoing

Recalled by BRS Analytical Services, LLC — Saint Louis, MO

FDA drug recall D-0404-2025 was initiated by BRS Analytical Services, LLC on Apr 23, 2025 and is designated Class II. Reason for recall: cGMP deviations and lack of assurance of sterility. The recall status is ongoing. Affected quantity: 13,872 cases (24 cartons per case).

Recall details

Product Type
Drugs
Report Date
May 14, 2025
Initiation Date
Apr 23, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,872 cases (24 cartons per case)

Product description

Artificial Tears Ophthalmic Solution, Dextran 70.01%/Glycerin 0.2%/Hypromellose 0.3% (Eye Lubricants) Lubricant Eye Drops, STERILE, 0.5 FL OZ (15 mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-043-15.

Reason for recall

cGMP deviations and lack of assurance of sterility.

Distribution pattern

Nationwide in the USA

Code information

Lot, expiry: Lot 126, exp 10/26/25; Lot 127, exp 10/30/25; Lot 128, exp 11/02/25; Lot 129, exp 11/06/25; Lot 162, exp 5/09/26; Lot 163, exp 5/14/26; Lot 164, exp 5/20/26; Lot 165, exp 5/23/26; Lot 166, exp 5/29/26; Lot 167, exp 6/03/26; Lot 168, exp 6/06/26; Lot 169, exp 6/10/26; Lot 170, exp 6/13/26; Lot 193, exp 10/07/26; Lot 194, exp 10/10/26; Lot 195, exp 10/14/26; Lot 196, exp 10/17/26; Lot 197, exp 10/21/26; Lot 198, exp 10/24/26; Lot 199, exp 10/30/26.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0404-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0404-2025. Report a data issue: hello@regdatalab.com.